Bristol Myers Squibb Opdivo in combo with cisplatin based chemotherapy gets EMA validation for Urothelial Carcinoma Ruchika Sharma31 Oct 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its type II variation application for...
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Surgery, Radiotherapy, Chemotherapy- What treatment to undergo?- Ft. Dr. Monique Gary, Breast Surgeon Dr. Monique Gary21 Oct 2023 1:51 PM ISTAlthough cancer can develop at any life stage, studies show that it is more common in old people. In a report on its website, the National Library of...
GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer Ruchika Sharma19 Oct 2023 2:41 PM ISTUK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
European Commission nod to Merck Keytruda for non-small cell lung cancer at high risk of recurrence Ruchika Sharma17 Oct 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
AstraZeneca gets USFDA priority review for Tagrisso plus chemotherapy for EGFR-mutated advanced lung cancer Ruchika Sharma17 Oct 2023 2:24 PM ISTCambridge: AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and...
Merck gets USFDA nod for neoadjuvant/ adjuvant Keytruda for resectable non-small cell lung cancer Ruchika Sharma17 Oct 2023 12:54 PM ISTThe approval marks the sixth NSCLC indication for KEYTRUDA.
Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma Ruchika Sharma24 Sept 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...
Merck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer Ruchika Sharma21 Sept 2023 5:33 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sept 2023 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer Ruchika Sharma12 Sept 2023 1:30 PM ISTCambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
